Tazidime

1-10%

Transient increases in transaminases (3-9%)

Eosinophilia (<7%)

Diarrhea (<2%)

Immune hypersensitivity reaction (2%)

Phlebitis (<2%)

Rash (maculopapular or erythematous) (2%)

Thrombocytosis (2%)

Injection site pain (1%)

<1%

Abdominal pain

Agranulocytosis

Angioedema

Asterixis

Coma

Dizziness

Encephalopathy

Fever

Hallucinations

Increased serum concentrations of bilirubin

Leukopenia

Lymphocytosis

Metallic taste

Myoclonia

Nausea or vomiting

Neuromuscular excitability

Neutropenia

Paresthesia

Photosensitivity

Pruritus

Seizures

Thrombocytopenia

Transient increases in blood urea nitrogen (BUN) or serum creatinine

Urticaria

Ceftazidime is a prescription medication used to treat bacterial infections, including lung, skin, bone, joint, brain, stomach, blood, urinary tract, and gynecological infections. Ceftazidime belongs to a group of drugs called cephalosporin antibiotics, which work to stop the growth of bacteria in the body.

This medication is available in an injectable form to be given directly into a vein (IV) or muscle (IM) by a healthcare professional.

Common side effects of ceftazidime include irritation at the site of injection, rash, nausea, diarrhea, and vomiting.

Serious side effects have been reported with ceftazidime including:

• hypersensitivity (severe allergic reaction). Signs of a hypersensitivity reaction, which include the following:
  • chest pain
  • swelling of the face, eyes, lips, tongue, arms, or legs
  • difficulty breathing or swallowing
  • fainting
  • rash
• diarrhea. Diarrhea is a common problem caused by antibiotics, and it usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as 2 or more months after having taken their last dose of the antibacterial. If diarrhea is severe or lasts more than 2 or 3 days, contact your doctor, as this may be a sign of an infection of the bowels.
• superinfection. Ceftazidime should not be used for extended periods. Prolonged use can lead to the growth of dangerous organisms that are resistant or unresponsive to this medication. Take ceftazidime for the duration prescribed by your doctor.
• bleeding abnormalities. Your health care provider may want to monitor lab tests that show how well your blood is able to clot or that measure your tendency to bleed. Any abnormalities or irregularities that may occur may be more common in those with kidney dysfunction.
• nervous system disturbances. Some may experience nervous symptom abnormalities such as a seizure or disturbances of consciousness (confusion, hallucinations, stupor, coma) when the dose of ceftazidime exceeds the recommended dose, especially in the presence of kidney dysfunction.

Do not take ceftazidime if you are allergic to ceftazidime or to any of its ingredients.